Immediate Impact
5 by Nobel laureates 59 standout
Citing Papers
Renal cell carcinoma
2024 Standout
Thyroid Cancer
2024 Standout
Works of Dave Carter being referenced
A phase 1b clinical trial of the multi-targeted tyrosine kinase inhibitor lenvatinib (E7080) in combination with everolimus for treatment of metastatic renal cell carcinoma (RCC)
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Dave Carter | 286 | 194 | 96 | 168 | 24 | 650 | |
| Philip Choi | 205 | 89 | 12 | 16 | 42 | 636 | |
| Michiko Ohkubo | 368 | 121 | 81 | 2 | 25 | 841 | |
| Rui-Jing Lu | 489 | 35 | 173 | 2 | 49 | 831 | |
| Kyle Lee | 239 | 113 | 73 | 1 | 38 | 757 | |
| Seong-Kook Lee | 300 | 159 | 211 | 18 | 587 | ||
| Tonghua Liu | 438 | 35 | 40 | 1 | 62 | 757 | |
| Koichi Nagasaki | 60 | 360 | 24 | 31 | 794 | ||
| P. Parisi | 487 | 82 | 18 | 30 | 780 | ||
| G. Baldo | 113 | 179 | 16 | 28 | 629 | ||
| Florent Duval | 184 | 70 | 187 | 12 | 643 |
All Works
Login with ORCID to disown or claim papers
Loading papers...